Viewing Study NCT02370706


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2026-03-01 @ 10:49 PM
Study NCT ID: NCT02370706
Status: COMPLETED
Last Update Posted: 2022-02-09
First Post: 2015-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module